Renagel and Catapres-tts-1 drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Renagel (sevelamer hydrochloride) and Catapres-tts-1 (clonidine). Common drug interactions include nephrogenic systemic fibrosis among females and cardiac failure congestive among males.
The phase IV clinical study analyzes what interactions people have when they take Renagel and Catapres-tts-1. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Renagel?
Renagel has active ingredients of sevelamer hydrochloride. eHealthMe is studying from 8,246 Renagel users. Check the latest studies of Renagel.
What is Catapres-tts-1?
Catapres-tts-1 has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 2,047 Catapres-tts-1 users. Check the latest studies of Catapres-tts-1.
16 people who take Renagel and Catapres-tts-1 together, and have interactions are studied.

What are the common drug interactions of Renagel and Catapres-Tts-1, by gender? *:
female:
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Laceration (tearing of soft body tissue)
- Mobility decreased (ability to move is reduced)
- Muscle fibrosis (fibrous muscle)
- Muscle spasms (muscle contraction)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Pain
- Pleural effusion (water on the lungs)
- Pneumonia
male:
- Cardiac failure congestive
- Erythema (redness of the skin)
- Fabry's disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells)
- Foot fracture
- Infusion related reaction
- Lymphoedema (localized fluid retention and tissue swelling)
- Pain
- Renal impairment (severely reduced kidney function)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
What are the common drug interactions of Renagel and Catapres-Tts-1, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Arthralgia (joint pain)
- Complex partial seizures (epileptic seizure)
- Herpes simplex (herpes simplex is a common viral infection)
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Muscle spasms (muscle contraction)
- Nausea (feeling of having an urge to vomit)
- Pneumonia
- Vomiting
30-39:
- Cardiac failure congestive
- Erythema (redness of the skin)
- Fabry's disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells)
- Foot fracture
- Infusion related reaction
- Lymphoedema (localized fluid retention and tissue swelling)
- Pain
- Renal impairment (severely reduced kidney function)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
40-49:
- Pain
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
- Pleural effusion (water on the lungs)
- Pneumonia
- Respiration (transport of oxygen from the outside air to the cells within tissues)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Urinary tract infection
- Vomiting
- Weight decreased
50-59:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Dry skin
- Emotional distress
- Erythema (redness of the skin)
- Excoriation (to tear or wear off the skin of)
- Gait disturbance
- Injury
- Joint range of motion decreased (disease of joint movement)
- Joint stiffness
60+:
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Pericardial effusion (fluid around the heart)
- Pleural effusion (water on the lungs)
- Pulmonary embolism (blockage of the main artery of the lung)
- Staphylococcal bacteraemia (a bacterial infection of blood)
- Unresponsive to stimuli
- Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
- Chest pain
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
What are the existing conditions these people have? *
- Stress And Anxiety: 3 people, 18.75%
- Nuclear Magnetic Resonance Imaging Brain: 3 people, 18.75%
- Vaginal Infection: 2 people, 12.50%
- Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 12.50%
- Blood Phosphorus Increased: 2 people, 12.50%
- Pain: 1 person, 6.25%
- Nausea And Vomiting: 1 person, 6.25%
- Nausea (feeling of having an urge to vomit): 1 person, 6.25%
- Medical Device Complication: 1 person, 6.25%
- Itching: 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Renagel and Catapres-tts-1?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Renagel (8,246 reports)
- Catapres-tts-1 (2,047 reports)
Browse all drug interactions of Renagel and Catapres-tts-1:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Renagel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Catapres-tts-1:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Renagel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Catapres-tts-1 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on sevelamer hydrochloride and clonidine (the active ingredients of Renagel and Catapres-tts-1, respectively), and Renagel and Catapres-tts-1 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Febuxostat and Rhabdomyolysis for Women aged 60+ - 9 seconds ago
- Pre-Eclampsia and drugs of ingredients of adalimumab - 10 seconds ago
- Drug interactions of Zoloft and Indocin - 10 seconds ago
- Xarelto and Rituxan drug interactions for men aged 60+ - 12 seconds ago
- Drug interactions of Pantoprazole Sodium and Carbamazepine - 12 seconds ago
- Drug interactions of Lexapro and Mestinon - 15 seconds ago
- Vitamin B12 and Shivering for Men aged 40-49 - 16 seconds ago
- Vitamin B12 and Rigors for Men aged 40-49 - 16 seconds ago
- Vitamin B12 and Chills for Men aged 40-49 - 17 seconds ago
- Could Lisinopril cause Weight Loss? - 18 seconds ago